CA Stock MarketDetailed Quotes
KNE Kane Biotech Inc
- 0.140
- +0.005+3.70%
15min DelayMarket Closed Jul 18 16:00 ET
18.55MMarket Cap-3500P/E (TTM)
0.145High0.140Low16.00KVolume0.145Open0.135Pre Close2.29KTurnover0.17052wk High0.02%Turnover Ratio132.51MShares0.05052wk Low-0.04EPS TTM11.92MFloat Cap4.500Historical HighLossP/E (Static)85.12MShs Float0.050Historical Low-0.04EPS LYR3.70%Amplitude--Dividend TTM-1.57P/B1Lot Size--Div YieldTTM
Kane Biotech Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 47.11%51.89K | -4.95%148.98K | -4.61%-1.9M | 25.57%717.85K | -21.71%657.31K | -93.76%35.27K | -90.25%156.73K | -542.07%-1.82M | 5.61%571.69K | 201.20%839.58K |
| Operating revenue | 47.11%51.89K | -4.95%148.98K | -4.61%-1.9M | 25.57%717.85K | 69.23%574.28K | -93.76%35.27K | -90.25%156.73K | -542.07%-1.82M | 5.61%571.69K | 21.75%339.35K |
| Cost of revenue | 66.27%11.84K | -11.62%39.51K | -21.80%-1.02M | 33.33%402.59K | -98.14%7.12K | -95.70%44.7K | -474.11%-839.42K | -26.29%301.95K | ||
| Gross profit | 42.26%40.05K | -2.28%109.47K | 10.12%-881.35K | 16.88%315.27K | -48.30%330.51K | -84.67%28.15K | -80.29%112.03K | -623.47%-980.55K | 104.87%269.74K | 664.76%639.22K |
| Operating expense | 35.72%1.23M | -2.88%3.47M | 17.95%-273.32K | 34.94%1.51M | -36.37%866.23K | -36.28%904.92K | -34.53%3.57M | -122.35%-333.11K | -34.86%1.12M | 24.85%1.36M |
| Selling and administrative expenses | 30.14%786.85K | -4.76%2.41M | -34.34%-681.53K | 21.05%1.24M | ---- | -43.40%604.64K | -37.82%2.53M | -153.36%-507.34K | -27.38%1.02M | ---- |
| -General and administrative expense | 30.14%786.85K | -4.76%2.41M | -34.34%-681.53K | 21.05%1.24M | ---- | -43.40%604.64K | -37.82%2.53M | -153.36%-507.34K | -27.38%1.02M | ---- |
| Research and development costs | 46.96%441.3K | 1.73%1.05M | 134.29%408.21K | 175.99%277.41K | -85.27%60.32K | -14.66%300.29K | -24.78%1.04M | -67.73%174.23K | -68.16%100.51K | 103.39%409.43K |
| Other operating expenses | ---- | ---- | ---- | ---- | -15.34%805.91K | ---- | ---- | ---- | ---- | --951.88K |
| Operating profit | -35.51%-1.19M | 2.90%-3.36M | 6.09%-608.03K | -40.66%-1.2M | 25.81%-535.72K | 29.09%-876.77K | 29.20%-3.46M | 50.33%-647.44K | 46.43%-851.6K | 28.28%-722.09K |
| Net non-operating interest income (expenses) | -33.65%-317.05K | -50.94%-1.21M | 10.45%-310.8K | -24.49%-259.66K | -105.46%-237.22K | -172.40%-801.2K | -222.72%-347.08K | -122.69%-208.58K | ||
| Non-operating interest income | --473 | -63.36%5.67K | 31.71%-44.46K | -39.79%17.57K | ---- | --0 | -87.32%15.46K | -357.03%-65.1K | -11.36%29.18K | ---- |
| Non-operating interest expense | 33.85%317.52K | 48.78%1.22M | -5.55%266.34K | 16.60%277.23K | ---- | 68.27%237.22K | 96.29%816.66K | 112.22%281.98K | 87.82%237.76K | ---- |
| Other net income (expenses) | 43,596.15%11.36K | -98.15%4.39K | 135.48%14.64K | -43.18%11.98K | -99.99%26 | -27.64%237.17K | -126.84%-41.27K | -78.99%21.08K | ||
| Gain on sale of security | 403.45%11.36K | 103.50%621 | 145.08%14.64K | -40.02%11.98K | ---- | -62.57%-3.74K | -546.04%-17.73K | -558.30%-32.48K | 457.85%19.97K | ---- |
| Other non-operating income (expenses) | ---- | -98.52%3.77K | --0 | ---- | ---- | -98.13%3.77K | -21.28%254.9K | -105.99%-8.79K | -98.85%1.11K | ---- |
| Income before tax | -34.10%-1.49M | -13.44%-4.56M | 12.71%-904.19K | -39.12%-1.45M | 3.32%-1.11M | 17.08%-4.02M | 17.61%-1.04M | 34.36%-1.04M | ||
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -8.21%-1.35M | -37.82%-5.27M | -92.32%-1.61M | -39.12%-1.45M | -21.81%-967.91K | -8.03%-1.24M | 21.15%-3.82M | 33.33%-838.15K | 34.36%-1.04M | 20.45%-794.6K |
| Net income continuous operations | -34.10%-1.49M | -13.44%-4.56M | 12.71%-904.19K | -39.12%-1.45M | -21.81%-967.91K | 3.32%-1.11M | 17.08%-4.02M | 17.61%-1.04M | 34.36%-1.04M | 20.45%-794.6K |
| Net income discontinuous operations | 212.42%146.96K | -458.08%-707.71K | ---- | ---- | ---- | ---130.72K | --197.64K | ---- | ---- | ---- |
| Noncontrolling interests | 212.42%49K | -458.09%-235.95K | -193.99%-29.83K | -142.74%-67.17K | -0.02%-43.58K | 126.86%65.89K | 172.55%31.74K | 54.01%-27.67K | ||
| Net income attributable to the company | -16.21%-1.4M | -29.41%-5.03M | -81.87%-1.58M | -36.28%-1.38M | 3.05%-872.54K | -8.34%-1.2M | 15.52%-3.89M | 31.44%-869.89K | 33.58%-1.01M | 0.50%-899.99K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -16.21%-1.4M | -29.41%-5.03M | -81.87%-1.58M | -36.28%-1.38M | 3.05%-872.54K | -8.34%-1.2M | 15.52%-3.89M | 31.44%-869.89K | 33.58%-1.01M | 0.50%-899.99K |
| Diluted earnings per share | 0.00%-0.01 | -33.33%-0.04 | -0.01 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 25.00%-0.03 | 0 | 0.00%-0.01 | 0.00%-0.01 |
| Basic earnings per share | 0.00%-0.01 | -33.33%-0.04 | -0.01 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 25.00%-0.03 | 0 | 0.00%-0.01 | 0.00%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg